Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Prepaid Assets (2011 - 2026)

Perspective Therapeutics' (CATX) quarterly Prepaid Assets came in at $4.4 million in Q2 2026, up 5.37% year-over-year from $4.2 million in Q2 2025, and little changed quarter-over-quarter from $4.4 million in Q1 2026.

Analysis

Perspective Therapeutics (CATX) Prepaid Assets (2011 - 2026) Analysis & Trends

Perspective Therapeutics has disclosed Prepaid Assets across 16 years of filings, most recently posting $4.4 million for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 5.37% year-over-year to $4.4 million; the TTM figure through Jun 2026 stood at $4.4 million (up 5.37% YoY), while the FY2025 annual figure was $3.6 million, down 11.68% from the prior year.
  • Prepaid Assets came in at $4.4 million for Q2 2026 at Perspective Therapeutics, roughly flat from $4.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.4 million in Q2 2026 to a low of $435000.0 in Q2 2022.
  • Average Prepaid Assets over 5 years is $2.2 million, with a median of $1.4 million recorded in 2023.
  • Year-over-year, Prepaid Assets slipped 17.2% in 2022 and soared 264.34% in 2024.
  • Over 5 years, Prepaid Assets stood at $443000.0 in 2022, then jumped by 155.76% to $1.1 million in 2023, then soared by 264.34% to $4.1 million in 2024, then slipped by 11.68% to $3.6 million in 2025, then climbed by 20.08% to $4.4 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $4.4 million in Q2 2026, $4.4 million in Q1 2026, and $3.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Perspective Therapeutics 361.95 Mn 361.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.38 Mn
Mar 31, 2026 4.37 Mn
Dec 31, 2025 3.65 Mn
Sep 30, 2025 4.18 Mn
Jun 30, 2025 4.16 Mn
Mar 31, 2025 3.96 Mn
Dec 31, 2024 4.13 Mn
Sep 30, 2024 2.11 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.13 Mn
Sep 30, 2023 961,000.00
Jun 30, 2023 1.43 Mn
Mar 31, 2023 1.04 Mn
Dec 31, 2022 443,000.00
Sep 30, 2022 662,000.00
Jun 30, 2022 435,000.00
Mar 31, 2022 551,000.00
Dec 31, 2021 535,000.00
Sep 30, 2021 306,000.00